Propranolol Biogen Dosage

How do you administer this medicine?
sponsored

Dosage of Propranolol Biogen in details

sponsored

Propranolol Biogen Dosage

Generic name: Propranolol Biogen HYDROCHLORIDE 60mg

Dosage form: capsule, extended release

See also:

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

General

Propranolol Biogen® LA provides Propranolol Biogen hydrochloride in a sustained-release capsule for administration once daily. If patients are switched from Propranolol Biogen Tablets to Propranolol Biogen Capsules, care should be taken to assure that the desired therapeutic effect is maintained. Propranolol Biogen should not be considered a simple mg-for-mg substitute for Propranolol Biogen. Propranolol Biogen has different kinetics and produces lower blood levels. Retitration may be necessary, especially to maintain effectiveness at the end of the 24-hour dosing interval.

Hypertension

The usual initial dosage is 80 mg Propranolol Biogen once daily, whether used alone or added to a diuretic. The dosage may be increased to 120 mg once daily or higher until adequate blood pressure control is achieved. The usual maintenance dosage is 120 to 160 mg once daily. In some instances a dosage of 640 mg may be required. The time needed for full hypertensive response to a given dosage is variable and may range from a few days to several weeks.

Angina Pectoris

Starting with 80 mg Propranolol Biogen once daily, dosage should be gradually increased at three- to seven-day intervals until optimal response is obtained. Although individual patients may respond at any dosage level, the average optimal dosage appears to be 160 mg once daily. In angina pectoris, the value and safety of dosage exceeding 320 mg per day have not been established.

If treatment is to be discontinued, reduce dosage gradually over a period of a few weeks.

Migraine

The initial oral dose is 80 mg Propranolol Biogen once daily. The usual effective dose range is 160 to 240 mg once daily. The dosage may be increased gradually to achieve optimal migraine prophylaxis. If a satisfactory response is not obtained within four to six weeks after reaching the maximal dose, Propranolol Biogen therapy should be discontinued. It may be advisable to withdraw the drug gradually over a period of several weeks depending on the patient's age, comorbidity, and dose of Propranolol Biogen.

Hypertrophic Subaortic Stenosis

The usual dosage is 80 to 160 mg Propranolol Biogen once daily.

More about Propranolol Biogen (Propranolol Biogen)

Consumer resources

Professional resources

Other formulations

Related treatment guides

What other drugs will affect Propranolol Biogen?

Tell your doctor about all medicines you use, and those you start or stop using during your treatment with Propranolol Biogen, especially:

This list is not complete. Other drugs may interact with Propranolol Biogen, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Propranolol Biogen interactions

sponsored

Propranolol Biogen hvdrochloride (Propranolol Biogen® (Propranolol Biogen) )

Patients receiving catecholamine-depleting drugs such as reserpine should be closely observed if Inderide is administered. The added catecholamine-blocking action may produce an excessive reduction of resting sympathetic nervous activity, which may result in hypotension, marked bradycardia, vertigo, syncopal attacks, or orthostatic hypotension.

Caution should be exercised when patients receiving a beta blocker are administered a calcium-channel blocking drug, especially intravenous verapamil, for both agents may depress myocardial contractility or atrioventricular conduction. On rare occasions, the concomitant intravenous use of a beta blocker and verapamil has resulted in serious adverse reactions, especially in patients with severe cardiomyopathy, congestive heart failure, or recent myocardial infarction.

Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia.

Blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by nonsteroidal anti-inflammatory drugs has been reported.

Hypotension and cardiac arrest have been reported with the concomitant use of Propranolol Biogen and haloperidol.

Aluminum hydroxide gel greatly reduces intestinal absorption of Propranolol Biogen.

Alcohol, when used concomitantly with Propranolol Biogen, may increase plasma levels of Propranolol Biogen.

Phenytoin, phenobarbitone, and rifampin accelerate Propranolol Biogen clearance.

Chlorpromazine, when used concomitantly with Propranolol Biogen, results in increased plasma levels of both drugs.

Antipyrine and lidocaine have reduced clearance when used concomitantly with Propranolol Biogen.

Thyroxine may result in a lower than expected TS concentration when used concomitantly with Propranolol Biogen.

Cimetidine decreases the hepatic metabolism of Propranolol Biogen, delaying elimination and increasing blood levels.

Theophylline clearance is reduced when used concomitantly with Propranolol Biogen.

Hydrochlorothiazide

Thiazide drugs may increase the responsiveness to tubocurarine.

Thiazides may decrease arterial responsiveness to norepinephrine. This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.

Insulin requirements in diabetic patients may be increased, decreased, or unchanged. Hypokalemia may develop during concomitant use of corticosteroids or ACTH.

Drug/Laboratory Test Interactions

Hydrochlorothiazide

Thiazides may decrease serum FBI levels without signs of thyroid disturbance.

Thiazides should be discontinued before carrying out tests for parathyroid function.


sponsored

References

  1. MeSH. "Vasodilator Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
  2. European Chemicals Agency - ECHA. "propranolol: The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.". https://echa.europa.eu/ (accessed September 17, 2018).
  3. PubMed Health. "Propranolol (By injection): This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Propranolol Biogen are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Propranolol Biogen. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported frequency of use

No survey data has been collected yet


Consumer reported doses

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 1 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved